Wegovy (Semaglutide) Weight Loss Injections

Wegovy® is a prescription-only weight loss injection that contains the active ingredient semaglutide. It is designed to support weight loss and long-term weight management in adults who meet specific clinical criteria.

Wegovy is taken once weekly using a pre-filled injection pen and is typically prescribed alongside a reduced-calorie diet and increased physical activity. It belongs to a group of medicines known as GLP-1 receptor agonists, which are also used in the treatment of type 2 diabetes.

In the UK, Wegovy is only available following a clinical assessment to ensure it is safe and appropriate for your individual health profile. At Happy Pharmacy, Wegovy is prescribed by qualified clinicians and dispensed by a UK GPhC-registered pharmacy.

Wegovy works by mimicking a naturally occurring hormone in the body called GLP-1 (glucagon-like peptide-1), which helps regulate appetite and food intake.

It supports weight loss in several key ways:

• Reduces appetite by acting on hunger signals in the brain
  
• Increases feelings of fullness after eating
  
• Slows stomach emptying, helping you feel satisfied for longer
  
• Helps reduce cravings, making it easier to control calorie intake
  

Together, these effects help you eat less without feeling excessively hungry, making it easier to maintain a calorie deficit over time.

Because Wegovy works on appetite regulation rather than metabolism alone, it is most effective when combined with healthy lifestyle changes, including diet and physical activity.

Wegovy® (semaglutide) is a clinically proven weight loss treatment supported by large-scale clinical trials. It is licensed in the UK by the MHRA for weight management in adults with obesity or weight-related health conditions.
Clinical studies have shown that Wegovy can help patients achieve meaningful and sustained weight loss when used alongside diet and lifestyle changes.

Wegovy has been shown in clinical studies to be an effective treatment for weight loss when used alongside a reduced-calorie diet and increased physical activity. Results can vary between individuals, but many patients experience meaningful and sustained weight loss over time.

Clinical trials show that Wegovy can help patients lose up to around 15% of their body weight when used consistently alongside lifestyle changes.

Clinical results and average weight loss

In large clinical trials involving adults with overweight or obesity, patients taking semaglutide (Wegovy’s active ingredient) achieved:

• Average weight loss of around 15% of their starting body weight
  
• Significant reductions in appetite and calorie intake
  
• Improvements in weight-related health markers
  

One of the most widely cited clinical studies, the STEP 1 trial, demonstrated that patients taking semaglutide experienced substantially greater weight loss compared to placebo when combined with lifestyle changes.

What affects how much weight you lose on Wegovy?

The level of weight loss achieved can depend on several factors, including:

• Your starting weight and body composition
  
• The dose prescribed and how your body responds to treatment
  
• Adherence to dietary and lifestyle guidance
  
• Consistency with weekly injections
  
• Underlying health conditions and metabolism

Is weight loss with Wegovy gradual?

Weight loss with Wegovy is typically gradual and progressive, with most patients noticing early appetite changes in the first few weeks, followed by more consistent weight loss as the dose increases. This steady approach supports safer, more sustainable results and long-term weight management.

Most people start Wegovy on a low dose and increase gradually over several weeks to help minimise side effects. While many patients progress to the maintenance dose, some achieve effective weight loss on lower doses depending on how their body responds to treatment. Dose increases are guided by your prescriber based on your progress and tolerance.

Individual results vary, and treatment should always be used under clinical supervision following a prescriber assessment.

For a more detailed breakdown, see our Wegovy weight loss timeline and results guide

Beyond its proven role in weight loss, Wegovy® has also demonstrated important benefits for heart health. The SELECT trial, a large-scale international study involving more than 17,000 adults with overweight or obesity and established cardiovascular disease, investigated whether Wegovy could reduce the risk of further cardiovascular events such as heart attack or stroke.

The results were significant: Wegovy was shown to lower the risk of major cardiovascular events by around 20%, regardless of the amount of weight lost during treatment. This finding highlights that Wegovy offers specific protective effects on the heart, independent of its impact on body weight.

Weight loss with Wegovy is gradual and progressive. Most patients begin to notice changes in appetite within the first few weeks, followed by more consistent weight loss as treatment continues and doses increase under clinical supervision.

Wegovy® is prescribed for adults who meet specific clinical criteria related to body weight and overall health.

• BMI of 30 or above (clinically obese)
  
• BMI of 27 or above with weight-related health conditions, such as high blood pressure, high cholesterol, pre-diabetes, or sleep apnoea
  

Eligibility is confirmed during an online consultation, where a qualified prescriber reviews your medical history, BMI, and overall suitability for treatment.

Wegovy may be prescribed for adults who meet specific clinical criteria based on their body mass index (BMI), medical history, and overall health. Eligibility is assessed during an online consultation by a qualified prescriber to ensure treatment is safe and appropriate.

You can use our BMI calculator to check your BMI and our Wegovy weight loss calculator to estimate how much weight you may lose during treatment before starting your consultation.

You can only buy Wegovy in the UK if it has been prescribed to you by a qualified healthcare professional following a clinical assessment.

To buy Wegovy online safely, you must first complete a medical consultation. This allows our UK-registered prescribers to review your health information, confirm that you meet the eligibility criteria, and ensure the treatment is appropriate for you.

If your consultation is approved, your prescription will be issued and your Wegovy injection will be dispensed by our GPhC-registered pharmacy. Your treatment will then be delivered securely and discreetly to your chosen address.

It’s important to only buy Wegovy from regulated UK providers. Prescription-only medicines should only be supplied by licensed pharmacies registered with the General Pharmaceutical Council (GPhC) and operating in line with MHRA guidelines. Buying from unregulated websites or social media sellers carries a risk of counterfeit or unsafe medication.

If you are unsure whether you qualify to buy Wegovy online, our consultation process will guide you through the eligibility criteria and next steps.

Wegovy is not suitable for everyone. During your online consultation, our clinicians will carefully assess your medical history to ensure treatment is safe and appropriate. You may not be suitable for Wegovy if any of the following apply:

Wegovy is not recommended during pregnancy.

Weight loss treatments are not considered safe during pregnancy, as they may affect the development of the baby. If you become pregnant while taking Wegovy, you should stop treatment and speak to your GP or prescriber as soon as possible.

If you are planning to become pregnant, you should discuss this with your clinician before starting Wegovy. In most cases, treatment will be paused in advance.

Wegovy is not recommended while breastfeeding.

It is not known whether semaglutide passes into breast milk, so a potential risk to the infant cannot be ruled out. For this reason, alternative approaches to weight management are usually recommended during this time.

If you are breastfeeding or planning to breastfeed, speak to your clinician about the most appropriate options for you.

Wegovy (semaglutide) can affect how some medicines work, particularly treatments taken by mouth, because it slows stomach emptying. This may change how quickly certain medicines are absorbed.

Before starting Wegovy, tell your prescriber about all medicines you take, including prescription medicines, over-the-counter treatments, supplements, and herbal products. This helps ensure treatment is safe and appropriate for you.

Particular care may be needed if you take medicines for diabetes, as combining Wegovy with insulin or sulfonylureas may increase the risk of low blood sugar. Wegovy should also not usually be used alongside another GLP-1 receptor agonist or weight-loss injection unless specifically advised by a clinician.

If you take the contraceptive pill, it is still important to mention this during your consultation. Although Wegovy is not known to reduce the effectiveness of oral contraception in the same way as some other weight-loss injections, vomiting or severe diarrhoea can affect absorption of the pill and may mean additional contraceptive precautions are needed.

If you are ever prescribed a new medicine while taking Wegovy, let your GP, pharmacist, or prescriber know that you are using semaglutide.

Wegovy is started at a low dose and increased gradually over time to help your body adjust and reduce the likelihood of side effects such as nausea.

Most people begin with 0.25mg once weekly, then increase step by step until they reach the maintenance dose if clinically appropriate. Some patients respond well at lower doses, while others benefit from progressing further depending on tolerability, appetite control, and weight-loss response.

Wegovy dosing is clinician-guided and reviewed throughout treatment. During your online check-ins, your prescriber will assess progress, side effects, and overall suitability to decide whether to maintain your current dose or increase gradually.

This step-by-step approach helps ensure treatment remains safe, effective, and tailored to your individual response.

The price of Wegovy in the UK depends on the strength you are prescribed. At Happy Pharmacy, you can buy Wegovy online from £89.99 for a 0.25mg 4-week pen. Each pen contains four once-weekly injections, which typically covers one month of treatment.

As treatment progresses, your prescriber may increase your dose gradually if clinically appropriate. Most patients start on 0.25mg in month one, increase to 0.5mg in month two, and step up further over time if needed. Because higher strengths cost more, the monthly price of Wegovy can increase as your dose increases.

When you buy Wegovy online from Happy Pharmacy, your price includes an online medical consultation, review by a UK-registered prescriber, and discreet delivery from a GPhC-registered pharmacy. Wegovy is only supplied where clinically appropriate following assessment.

Wegovy is supplied as a pre-filled, multi-dose injection pen (FlexTouch pen) designed for once-weekly use. It is injected on the same day each week, at any time of day, with or without food.

Each pen contains multiple doses, and a new needle should be used for every injection. Rotating injection sites helps reduce skin irritation and supports consistent absorption. Most people find the pen simple to use after initial guidance from their prescriber.

If you are unsure how to use your pen, your clinician will provide instructions during your consultation. You should also follow the manufacturer’s instructions included with the Wegovy patient information leaflet.

Wegovy should be injected into the fatty tissue of the abdomen, upper thigh, or upper arm. Avoid injecting into the same spot each time and rotate injection sites weekly to reduce irritation. The upper arm is usually only used if someone else is administering the injection.

Many people are initially concerned about self-injection, but the Wegovy FlexTouch pen is designed to make the process simple and nearly pain-free. It is easy to use at home and comes with clear step-by-step instructions to guide you through each injection. Your prescriber and pharmacist are available if you need support or reassurance at any stage.

Like all prescription medicines, Wegovy can cause side effects, although not everyone will experience them. Most side effects are mild to moderate, occur early in treatment, and often improve as your body adjusts to the medication. Side effects are more likely when starting treatment or after a dose increase, which is why Wegovy is typically started at a low dose and increased gradually under clinical supervision.

This section outlines common and less common side effects, what to expect during treatment, and when to seek medical advice.

The table below outlines common Wegovy side effects that are usually manageable at home, as well as less common but more serious symptoms that require medical advice.

Side effects are most common when starting Wegovy or increasing your dose. Most are mild and improve as your body adjusts. The guidance below covers practical ways to manage common symptoms and when to seek medical advice.

Most people experience only mild digestive symptoms that settle within a few weeks, particularly when doses are increased gradually.

Mild redness, itching, bruising, or tenderness around the injection site can happen, particularly early in treatment. Rotating injection sites and using good technique usually helps.

• Rotate the site each week
  
• Let the pen warm to room temperature if stored in the fridge (do not heat)
  
• Avoid injecting into irritated, bruised, scarred, or inflamed skin
  
• Seek advice if the reaction spreads, becomes very painful, or you develop hives or swelling
  

If side effects are troublesome, your prescriber may recommend staying on your current dose for longer before increasing. This gives your body more time to adjust and may help symptoms settle. Do not change your dose without clinician advice.

If you experience side effects that are persistent, worsening, or affecting your day-to-day life, our clinical team is here to help. If you are considering starting treatment and would like to know how to buy Wegovy safely, our prescribers can guide you through the eligibility assessment and consultation process.

You can contact Happy Pharmacy at any point during treatment if you have concerns about side effects, dosing, or how your body is responding to Wegovy. Our GPhC-registered pharmacists and prescribers will review your symptoms and advise on next steps.

If you feel very unwell or develop severe symptoms, seek urgent medical advice via NHS 111 or A&E.

Mounjaro (tirzepatide) is one of the main alternatives to Wegovy. Both are prescription weight loss injections used alongside diet and lifestyle changes, but they work slightly differently.

Wegovy contains semaglutide and works by targeting the GLP-1 receptor to reduce appetite, slow digestion, and help you feel fuller for longer. Mounjaro contains tirzepatide and targets both GLP-1 and GIP receptors. This dual action may make Mounjaro more effective for some patients, although suitability depends on your medical history, treatment goals, and how well you tolerate each medicine.

Your Happy Pharmacy prescriber can assess your eligibility and advise whether Wegovy is the most appropriate option for you or whether an alternative such as Mounjaro may be more suitable.

Read our comprehensive guide on the differences between Mounjaro and Wegovy for further information.

If you are considering changing treatment, speak to your prescriber before switching, as dosing, side effects, and treatment response should all be reviewed carefully.